Dr. Sunil Gupta
MBBS, MD (Medicine), DM (Medical Oncology) from Cancer Institute Adyar, Madras.
He has trained at the Memorial Slom Kettering Cancer Centre, New York, U.S.A., Fred Hutchinson Cancer Research Centre
Seattle, U.S.A., M.D Anderson Cancer Centre, Houston Texas, U.S.A., James Cancer Centre & Research Hospital Columbus, Ohio, U.S.A.
He is the chief Investigator Phase II trials of CA Gall Bladder, CA Ovary, CA recurrent breast cancer, CA Lung (Role of Gene Therapy); BCIRG Phase III trial of CA breast.
He presented a paper in UICC ( Bangladesh ) on CPT - 11 on metastatic CA Lung 2000.
He presented a paper in ASCO ( San Francisco ), USA on Phase II CA Gall Bladder 2000.
He presented a paper in ASCO (New Orlando) USA, on Phase II CA Ovary 2003.
He presented a paper in Asia Pacific Lung Cancer Conference Thailand August 2004.
He attends and participates in all National and International conferences of Oncology.
He is a member of the American Society of Oncology (ASCO).
He is a life member of IMA & DMA.
He has worked as Senior Consultant of Hemato-Medical Oncology in Dharamshila Cancer Hospital and Research Centre, Delhi for more than seven years.
He was a faculty of DNB Medical Oncology at DCH&RC.
He is a Chief Investigator in Phase II from USA & Canada trials.
He is currently the Investigator in Phase II global trials on gene therapy in Lung Cancer and Phase III BCIRG Global Trials on CA breast.
Presently he is working as Senior Consultant of Haemato-Medical Oncology in Fortis Hospital, Noida and Fortis Jessa Ram Hospital, Karol Bagh.